Pharmena S.A. (WSE:PHR)

Poland flag Poland · Delayed Price · Currency is PLN
2.970
-0.030 (-1.00%)
At close: Dec 12, 2025
-28.26%
Market Cap33.08M
Revenue (ttm)1.27M
Net Income (ttm)-2.20M
Shares Out11.14M
EPS (ttm)-0.20
PE Ration/a
Forward PEn/a
Dividend0.85 (28.62%)
Ex-Dividend Daten/a
Volume11,337
Average Volume4,732
Open2.960
Previous Close3.000
Day's Range2.950 - 3.010
52-Week Range2.830 - 4.790
Beta0.48
RSI32.16
Earnings DateNov 28, 2025

About Pharmena

Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including face, hair, and body care products, as well as dietary supplement. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PHR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.